Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
8,694,763
-
Share change
-
+385,435
-
Total reported value
-
$715,832,401
-
Put/Call ratio
-
114%
-
Price per share
-
$82.33
-
Number of holders
-
91
-
Value change
-
+$32,165,203
-
Number of buys
-
59
-
Number of sells
-
31
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2014
As of 30 Jun 2014 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,694,763 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, FIRST TRUST ADVISORS LP, UBS AG, BANK OF AMERICA CORP /DE/, RiverFront Investment Group, LLC, RAYMOND JAMES & ASSOCIATES, GOLDMAN SACHS GROUP INC, LPL Financial LLC, and ROYAL BANK OF CANADA.
This table shows 91 institutional shareholders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.